The Animalcare Board is proposing a final dividend of 3.0 pence per share (2023: 3.0 pence per share). Subject to shareholder approval at the Annual General Meeting to be held on Tuesday 10 June 2025, the final dividend will be paid on Friday 18 July 2025 to shareholders whose names are on the Register of Members at close of business on Friday 20 June 2025. The ordinary shares will become ex-dividend on Thursday 19 June 2025.
Other financial highlights include:
Revenues from continuing operations increased by 4.9% (7.2% at CER) to £74.2m with sales growth delivered across all three product categories
Gross margins eased to 55.6% (2023: 56.8%) due the impact of input inflation and unfavourable exchange rates, offset by positive sales mix
Continued targeted investment in people and marketing reflected in underlying EBITDA at £11.6m, in line with prior year
Reported profit before tax of £5.8m (2023: £3.3m)
Underlying continuing earnings per share of 10.9 pence, up 10.1%; reported basic earnings per share of 30.3 pence (2024: 2.0p) boosted by the disposals of Identicare and STEM
Cash conversion rate of 103.1% well ahead of prior year
Following the equity raise and acquisition of Randlab the balance sheet remains strong with net debt standing at £9.0m at year end excluding lease liabilities, with leverage comfortably within the Board's stated guidance of <2.0x underlying EBITDA
